Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial

  • STATUS
    Recruiting
  • End date
    Oct 31, 2022
  • participants needed
    54
  • sponsor
    Medecins Sans Frontieres, Netherlands
Updated on 24 May 2021
linezolid
moxifloxacin
bedaquiline
clofazimine
pretomanid

Summary

PRACTECAL-PRO is a sub-study of a TB-PRACTECAL clinical trial for multidrug resistant Tuberculosis. It evaluates the effectiveness of TB-PRACTECAL interventions from the patient perspective in terms of their quality of life, shared decision making and satisfaction with services.

Description

Tolerability of drugs for TB is a complex and dynamic course for patients with drug resistance and can be affected by many different factors. A deeper understanding of the perspectives and experience of men and women participating in novel TB treatment trials will add to the understanding of the safety and efficacy of treatment.

TB-PRACTECAL is a multicentre, open label, phase 2-3 randomised controlled trial evaluating exclusively oral 6 months regimens containing bedaquiline, pretomanid, linezolid +/- moxifloxacin or clofazimine for the treatment of microbiologically confirmed pulmonary M/XDR-TB. It is registered with the ClinicalTrials.gov with identifier number NCT02589782. The trial aims to recruit 630 adults from two sites in Uzbekistan (Nukus and Tashkent) and one site each from Belarus and South Africa.

The TB-PRACTECAL trial assumes that even if the investigational arms would have non-inferior efficacy and safety compared to the standard of care outcomes, patients would prefer a shorter, exclusively oral regimen with a lower pill count. This study therefore aims to describe patient experiences (i.e. the quality of the treatment experience as opposed to the quantity of treatment or the amount of time spent on it).

The PRACTECAL-PRO sub-study aims to answer the question: "What are the perceptions, expectations and experiences of novel TB treatment for adult patients participating in a six-month regimen clinical trial in Uzbekistan, South Africa and Belarus?"

The objectives for the analysis are:

  • To compare baseline scores between trial patients (all interventional arm patients plus standard of care patients) with healthy controls.
  • To assess changes in scores over time in patients on the intervention arms and patients on the standard of care arm.
  • To assess the utility of the SF 12 and SGRQ in a TB clinical trial.

Details
Condition drug-resistant tuberculosis
Treatment moxifloxacin, bedaquiline, linezolid, pretomanid, Clofazimine, Directly observed therapy (DOT)
Clinical Study IdentifierNCT03942354
SponsorMedecins Sans Frontieres, Netherlands
Last Modified on24 May 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Patients recruited into the TB-PRACTECAL trial in the approved sites OR
Local healthy-controls of a similar profile in terms of age and gender aged 18 years AND
Literate in the study questionnaire languages
Able to sign the sub-study informed consent form after agreeing to the additional interviews and completion of questionnaires

Exclusion Criteria

TB patients excluded from TB-PRACTECAL clinical trial
Healthy volenteers with co-morbidities
Healthy volenteers found to have TB
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note